Full text is available at the source.
Urine metabolite changes linked to Guizhi Fuling capsule treatment in rats with primary menstrual pain
Updated
Abstract
A total of 36 potential biomarkers were identified that may be involved in metabolic pathways related to primary dysmenorrhea.
- Primary dysmenorrhea (PD) is associated with disruptions in various metabolic pathways, including the TCA cycle and lipid metabolism.
- Guizhi Fuling capsule (GFC) may exert therapeutic effects on PD by regulating multiple metabolic processes.
- The study utilized advanced techniques to analyze both non-polar and polar metabolites in urine.
- Identified biomarkers could play a role in the early diagnosis and prediction of primary dysmenorrhea.
Simplified